Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia

Leukemia. 2011 Feb;25(2):375-9. doi: 10.1038/leu.2010.273. Epub 2010 Nov 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activin Receptors, Type II / analysis
  • Adult
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / pathology*
  • Male
  • Middle Aged
  • Prognosis
  • Protein Serine-Threonine Kinases / analysis*
  • Receptor, Transforming Growth Factor-beta Type I
  • Receptors, Transforming Growth Factor beta / analysis*
  • Treatment Outcome
  • Young Adult

Substances

  • Receptors, Transforming Growth Factor beta
  • Protein Serine-Threonine Kinases
  • ACVRL1 protein, human
  • Activin Receptors, Type II
  • Receptor, Transforming Growth Factor-beta Type I
  • TGFBR1 protein, human